首页> 美国卫生研究院文献>Cells >Drug Crystal-Related Gastrointestinal Complications Involve Crystal-Induced Release of Neutrophil and Monocyte Extracellular Traps
【2h】

Drug Crystal-Related Gastrointestinal Complications Involve Crystal-Induced Release of Neutrophil and Monocyte Extracellular Traps

机译:药物晶体相关的胃肠并发症涉及晶体诱导的中性粒细胞和单核细胞细胞外陷阱的释放

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Ion-exchange resins are commonly used to manage complications of chronic kidney disease, such as hyperphosphatemia, hyperkalemia, and hypercholesterolemia. Occasionally, these drugs can irritate the gastrointestinal lining and cause life-threatening intestinal necrosis. Currently, the pathophysiology of drug crystal-induced intestinal necrosis is not well understood. We hypothesized that crystals of ion-exchange resins like sevelamer, polystyrene sulfonate, and cholestyramine can trigger the formation of neutrophil and monocyte extracellular traps by contributing to intestinal barrier dysfunction. Light and fluorescence microscopy of the colonic resection specimen from a patient with chronic kidney disease revealed severe intestinal necrosis, ulceration, sevelamer crystals, and inflammation upon oral intake of sevelamer, as well as the formation of neutrophil extracellular traps in proximity to small sevelamer crystals. Indeed, drug crystals reduced metabolic activity and induced barrier dysfunction and cell death in human intestinal epithelial cells in vitro. In addition, drug crystals triggered the release of neutrophil and monocyte extracellular traps. Taken together, these data raise the possibility that besides other factors including chronic kidney disease, diabetes mellitus, and hypertension, drug crystals may further amplify a pre-existing barrier dysfunction and necroinflammation in a crescendo of local intestinal necrosis and systemic inflammation/infection, as occasionally observed in patients on ion-exchange resin therapy.
机译:离子交换树脂通常用于管理慢性肾病的并发症,例如高磷脂血症,高钾血症和高胆固醇血症。偶尔,这些药物可以刺激胃肠道衬里并导致危及生命的肠道坏死。目前,药物晶体诱导的肠道坏死的病理生理学尚不清楚。我们假设离子交换树脂等离子交换树脂,如eVelamer,聚苯乙烯磺酸盐和胆甾胺,可以通过促进肠道屏障功能障碍来引发中性粒细胞和单核细胞细胞外捕集的形成。来自慢性肾病的患者的结肠切除样本的光和荧光显微镜显露出严重的肠道坏死,溃疡,evelamer晶体和口服口服摄入虫子的炎症,以及在邻近的小sevelamer晶体附近形成中性粒细胞细胞外捕集器。实际上,药物晶体在体外降低代谢活性,并诱导人类肠上皮细胞中的阻隔功能障碍和细胞死亡。此外,药物晶体引发释放中性粒细胞和单核细胞细胞外陷阱。这些数据携带,这些数据引起了其他因素,除了包括慢性肾病,糖尿病和高血压等因素,药物晶体可以进一步扩增局部肠道坏死和全身炎症/感染的Crescendo中的预先存在的屏障功能障碍和NeCroin炎症,如偶尔在离子交换树脂疗法患者中观察到。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号